RFA-CA-21-059 - The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The National Cancer Institute (NCI) intends to reissue the F99/K00 Predoctoral to Postdoctoral Fellow transition Award Funding Opportunity Announcement (FOA), which aims to identify and encourage outstanding graduate students who are recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate their successful transition to postdoctoral positions and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. PhD students in all areas of biomedical, behavioral, or clinical research at a domestic institution are encouraged to apply. The FOA is intended to be a re-issuance of RFA-CA-21-059.
This Notice is being provided to allow sufficient time for institutions to nominate candidates and for applicants to develop strong applications.
This Notice encourages outstanding late-stage Ph.D. students to begin to consider applying for this reissued FOA. The F99/K00 award is intended for individuals who require 1-2 years to complete their Ph.D. dissertation research training (F99 phase) before transitioning to mentored postdoctoral research training (K00 phase). Consequently, applicants are expected to propose an individualized research training plan for the next 1-2 years of dissertation research training and a plan for 3-4 years of mentored postdoctoral research and career development activities that will prepare them for independent cancer-focused research careers.
The F99/K00 award is meant to provide up to 6 years of support in two phases. The initial (F99) phase will provide support for 1-2 years of dissertation research (final experiments, dissertation preparation, and selection of a postdoctoral mentor). The second (K00) phase will provide up to 4 years of mentored postdoctoral research and career development support, contingent upon successful completion of the doctoral degree requirements and securing a cancer-focused postdoctoral position at a new institution. The two award phases are intended to be continuous in time. A K00 award will be made only to a PD/PI who has successfully completed the F99-supported training, secured a cancer-focused postdoctoral appointment, and provided NCI with a strong research and career development plan.
This initiative is open to Ph.D. students in all areas of biomedical, behavioral, or clinical research. There is no citizenship requirement for F99 applicants. An applicant may be a citizen or a non-citizen national of the United States, has been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen holding a valid U.S. visa.
The program website (NCI F99/K00) has a lot of resources including a video presentation about the program overview, the eligibility and nomination requirements, the different components of the application, and the application peer-review process.
The budget for up to two years of F99 support includes stipend, institutional allowance, travel to NCI annual meeting, and tuition. An estimated award ceiling for a 2-year F99 phase is $88,964 total costs based on current NRSA stipend levels (NOT-OD-22-132). The budget for up to four years of K00 support includes salary, institutional allowance, travel to NCI annual meeting, tuition, fringe and benefits, and indirect cost. An estimated award ceiling for a 4-year K00 phase is $364,356 total costs.
Applications are not being solicited at this time.
Please direct all inquiries to:
Mariam Eljanne, Ph.D.
National Cancer Institute (NCI)